Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Archives

You are currently viewing the 2008 archives
Click here to return to the current data set

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: ganciclovir sodium

« Back to Dashboard

Ganciclovir sodium is the generic ingredient in two branded drugs marketed by Roche Palo, Fresenius Kabi Usa, Luitpold, and Eurohlth Intl, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-one drug master file entries for ganciclovir sodium. One supplier is listed for this compound.

Summary for Generic Name: ganciclovir sodium

Drug Master File Entries: see list21
Suppliers: see list1
Therapeutic Class:Antivirals

Pharmacology for Ingredient: ganciclovir sodium

Clinical Trials for: ganciclovir sodium

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Exclusivity Expiration
Roche Palo
ganciclovir sodium
INJECTABLE; INJECTION019661Jun 23, 1989RXYes<disabled><disabled>
ganciclovir sodium
INJECTABLE; INJECTION076222Jul 16, 2003RXNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology